Skip to main content

SYNAPTICS Inc (SYNA) Stock Forecast 2025 - AI Price Prediction & Analysis


SYNAPTICS Inc (SYNA) AI Stock Price Forecast & Investment Analysis

SYNAPTICS Inc Stock Price Chart and Technical Analysis

Loading SYNAPTICS Inc interactive price chart and technical analysis...

SYNAPTICS Inc (SYNA) - Comprehensive Stock Analysis & Investment Research

Deep dive into SYNAPTICS Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about SYNAPTICS Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For SYNAPTICS Inc: SYNAPTICS Inc operates in the Manufacturing sector, establishing it as a mid-cap growth opportunity.

SYNAPTICS Inc (Stock Symbol: SYNA) is a leading company in the Manufacturing sector , specifically operating within the Semiconductors & Related Devices industry.

The organization employs approximately 1771 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing SYNAPTICS Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SYNAPTICS Inc: With $1074M in annual revenue and 12.2% net margin, the company demonstrates solid profitability.

Annual Revenue: $1074 million generating a 12.2% net profit margin .

Market Capitalization: $2794 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): 18.5% - Excellent shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for SYNAPTICS Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For SYNAPTICS Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for SYNAPTICS Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: SYNAPTICS Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For SYNAPTICS Inc: Strong free cash flow generation demonstrates solid operational efficiency.

SYNAPTICS Inc strategically competes in the highly dynamic Semiconductors & Related Devices marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company demonstrates robust operational efficiency through strong free cash flow generation of $381 million annually, complemented by impressive 43.9% year-over-year cash flow growth.

The company maintains a healthy 41.0% gross margin, indicating strong pricing power and operational efficiency.

SYNAPTICS Inc (SYNA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for SYNAPTICS Inc stock analysis.

Loading SYNAPTICS Inc comprehensive fundamental analysis and insider trading data...

Deep dive into SYNAPTICS Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if SYNAPTICS Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For SYNAPTICS Inc: With a P/E ratio of 15.86, the market moderately values the company's earnings.

P/E Ratio 15.86x
P/B Ratio 2.00x
Market Cap $2794M
EPS $-1.22
Book Value/Share $35.50
Revenue/Share $27.34
FCF/Share $6.69
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently SYNAPTICS Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SYNAPTICS Inc: An ROE of 18.5% demonstrates excellent shareholder value creation.

ROE 18.5%
ROA 7.9%
ROIC 10.7%
Gross Margin 41.0%
Operating Margin 14.6%
Net Margin 12.2%
EBT Margin 15.5%
Tax Rate 19.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess SYNAPTICS Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For SYNAPTICS Inc: A current ratio of 3.17 indicates strong liquidity.

Current Ratio 3.17x
Quick Ratio 2.68x
D/E Ratio 0.90x
Financial Leverage 2.33x
Interest Coverage 9.2x
Working Capital $393M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal SYNAPTICS Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For SYNAPTICS Inc: Free cash flow of $381M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $413M
Free Cash Flow $381M
Capital Spending $-33M
OCF Growth YoY 43.9%
FCF Growth YoY 46.9%
FCF/Sales 23.9%
CapEx/Sales 2.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively SYNAPTICS Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For SYNAPTICS Inc: An asset turnover of 0.65x suggests room for improvement in asset utilization.

Asset Turnover 0.65x
Receivables Turnover 6.0x
Inventory Turnover 6.9x
Fixed Assets Turnover 20.1x
Days Sales Outstanding 61 days
Days Inventory 53 days
Payables Period 60 days
Cash Conversion Cycle 54 days
Understanding Financial Statement Data

What these metrics mean: Key figures from SYNAPTICS Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For SYNAPTICS Inc: With annual revenue of $1074M, SYNAPTICS Inc operates at significant scale.

Income Statement ($ Millions)
Total Revenue $1074M
Operating Income $89M
Net Income $74M
R&D Expense $100M
SG&A Expense $10M
Cost of Goods Sold $361M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 46%
Cash & Short-term Investments 28%
Total Liabilities 57%
Short-term Debt 22%
Accounts Receivable 11%
Inventory 5%
Dividend & Shareholder Information
Shares Outstanding 39M
Growth Metrics (YoY)
EPS Growth 2.9%

Latest SYNAPTICS Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting SYNAPTICS Inc (SYNA) stock price and investment outlook.

, source: The Motley Fool

Good day, and thank you for standing by. Welcome to the Synaptics, Inc. First Quarter Fiscal Year 2022 Financial Results Conference Call. [Operator Instructions] I would now like to hand the ...

SYNAPTICS Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of SYNAPTICS Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAOI Unlock Forecast - 30 Days FREE Trial $1647M -17.5x 3.9x
ADI Unlock Forecast - 30 Days FREE Trial $123077M 62.9x 3.6x
ADTTF Unlock Forecast - 30 Days FREE Trial $15603M x 0.1x
AIP Unlock Forecast - 30 Days FREE Trial $377M -10.4x -85.5x
ALAB Unlock Forecast - 30 Days FREE Trial $41071M 410.1x 36.2x
ALGM Unlock Forecast - 30 Days FREE Trial $5652M 76.2x 6.1x
ALMU Unlock Forecast - 30 Days FREE Trial $286M x 15.9x
AMAT Unlock Forecast - 30 Days FREE Trial $132534M 19.4x 6.8x
AMBA Unlock Forecast - 30 Days FREE Trial $3410M -17.3x 6.0x
AMD Unlock Forecast - 30 Days FREE Trial $259731M 91.7x 4.4x
AMKR Unlock Forecast - 30 Days FREE Trial $6195M 20.4x 1.5x
AOSL Unlock Forecast - 30 Days FREE Trial $839M -88.3x 1.0x
ASTI Unlock Forecast - 30 Days FREE Trial $5M -0.1x 1.6x
ATEYY Unlock Forecast - 30 Days FREE Trial $17344M x 0.1x
ATOM Unlock Forecast - 30 Days FREE Trial $99M -3.5x 4.6x
AVGO Unlock Forecast - 30 Days FREE Trial $1355587M 149.7x 34.3x
AXTI Unlock Forecast - 30 Days FREE Trial $192M -7.3x 1.1x
BEEM Unlock Forecast - 30 Days FREE Trial $44M -2.9x 1.6x
BRKH Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BRKHU Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BRKHW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BZAI Unlock Forecast - 30 Days FREE Trial $489M x 29.3x
BZAIW Unlock Forecast - 30 Days FREE Trial $M x x
CRDO Unlock Forecast - 30 Days FREE Trial $30263M 241.9x 38.7x
CRUS Unlock Forecast - 30 Days FREE Trial $6007M 17.2x 3.1x
CSLR Unlock Forecast - 30 Days FREE Trial $152M -0.2x -1.6x
CSLRW Unlock Forecast - 30 Days FREE Trial $6M x 0.0x
DIOD Unlock Forecast - 30 Days FREE Trial $2545M 40.0x 1.4x
DQ Unlock Forecast - 30 Days FREE Trial $12469M x 5.8x
DVLT Unlock Forecast - 30 Days FREE Trial $27M x 0.4x
EMKR Unlock Forecast - 30 Days FREE Trial $28M -0.9x 0.6x
ENPH Unlock Forecast - 30 Days FREE Trial $5038M 28.8x 5.7x
FORM Unlock Forecast - 30 Days FREE Trial $2372M 54.0x 2.4x
FSLR Unlock Forecast - 30 Days FREE Trial $21901M 17.4x 2.6x
FTCI Unlock Forecast - 30 Days FREE Trial $93M -8.3x 10.3x
GCTS Unlock Forecast - 30 Days FREE Trial $74M x -1.2x
GSIT Unlock Forecast - 30 Days FREE Trial $85M -4.5x 2.3x
GUER Unlock Forecast - 30 Days FREE Trial $-3M x x
HIMX Unlock Forecast - 30 Days FREE Trial $2892M x 6.3x
HYSR Unlock Forecast - 30 Days FREE Trial $172M x 4.6x
ICG Unlock Forecast - 30 Days FREE Trial $212M x 1.6x
ICHR Unlock Forecast - 30 Days FREE Trial $578M -30.4x 0.8x
INDI Unlock Forecast - 30 Days FREE Trial $801M -8.3x 2.1x
INTC Unlock Forecast - 30 Days FREE Trial $107898M -6.2x 1.1x
IPGP Unlock Forecast - 30 Days FREE Trial $3485M -756.9x 1.7x
IPWR Unlock Forecast - 30 Days FREE Trial $43M -5.9x 3.4x
JKS Unlock Forecast - 30 Days FREE Trial $5373M x 0.5x
KLIC Unlock Forecast - 30 Days FREE Trial $2067M 347.4x 2.5x
KOPN Unlock Forecast - 30 Days FREE Trial $352M -3.2x 17.0x
LAES Unlock Forecast - 30 Days FREE Trial $58M x 11.2x
LASR Unlock Forecast - 30 Days FREE Trial $1453M -10.7x 6.7x
LEDS Unlock Forecast - 30 Days FREE Trial $14M -3.6x 3.5x
LPTH Unlock Forecast - 30 Days FREE Trial $148M -8.8x 9.4x
LSCC Unlock Forecast - 30 Days FREE Trial $9110M 287.9x 13.3x
MAXN Unlock Forecast - 30 Days FREE Trial $192M x 4.5x
MCHP Unlock Forecast - 30 Days FREE Trial $34939M 28.8x 5.1x
MCHPP Unlock Forecast - 30 Days FREE Trial $32645M x 4.8x
MOBX Unlock Forecast - 30 Days FREE Trial $45M x 105.9x
MOBXW Unlock Forecast - 30 Days FREE Trial $3M x 0.3x
MPWR Unlock Forecast - 30 Days FREE Trial $41059M 22.1x 12.1x
MRAM Unlock Forecast - 30 Days FREE Trial $147M 89.1x 2.3x
MRVL Unlock Forecast - 30 Days FREE Trial $58578M -40.1x 4.4x
MTSI Unlock Forecast - 30 Days FREE Trial $9723M 139.1x 7.7x
MU Unlock Forecast - 30 Days FREE Trial $157220M 25.3x 3.1x
MX Unlock Forecast - 30 Days FREE Trial $111M -3.9x 0.4x
MXL Unlock Forecast - 30 Days FREE Trial $1380M -4.6x 2.8x
NA Unlock Forecast - 30 Days FREE Trial $550M x 17.2x
NVDA Unlock Forecast - 30 Days FREE Trial $4357175M 50.3x 43.5x
NVEC Unlock Forecast - 30 Days FREE Trial $327M 22.5x 5.4x
NVTS Unlock Forecast - 30 Days FREE Trial $749M -15.1x 2.0x
NXPI Unlock Forecast - 30 Days FREE Trial $57932M 27.0x 6.1x
ON Unlock Forecast - 30 Days FREE Trial $20170M 43.3x 2.5x
OSIS Unlock Forecast - 30 Days FREE Trial $3549M 25.6x 4.0x
PENG Unlock Forecast - 30 Days FREE Trial $1438M -13.5x 2.5x
PLAB Unlock Forecast - 30 Days FREE Trial $1864M 17.2x 1.7x
POWI Unlock Forecast - 30 Days FREE Trial $2531M 75.4x 3.6x
PRSO Unlock Forecast - 30 Days FREE Trial $8M -0.1x 2.5x
PXLW Unlock Forecast - 30 Days FREE Trial $-57M -1.7x -18.9x
QRVO Unlock Forecast - 30 Days FREE Trial $8363M 103.5x 2.4x
QUIK Unlock Forecast - 30 Days FREE Trial $84M -651.3x 3.0x
RBCN Unlock Forecast - 30 Days FREE Trial $11M 11.5x 3.3x
RMBS Unlock Forecast - 30 Days FREE Trial $8377M 36.6x 6.8x
SEDG Unlock Forecast - 30 Days FREE Trial $1811M -0.9x 3.5x
SEVCF Unlock Forecast - 30 Days FREE Trial $157M x x
SHLS Unlock Forecast - 30 Days FREE Trial $1157M 54.8x 2.0x
SITM Unlock Forecast - 30 Days FREE Trial $6386M -44.5x 5.8x
SKYT Unlock Forecast - 30 Days FREE Trial $611M -20.5x 13.5x
SLAB Unlock Forecast - 30 Days FREE Trial $4448M -18.2x 4.2x
SMTC Unlock Forecast - 30 Days FREE Trial $5356M 224.7x 9.4x
SMTK Unlock Forecast - 30 Days FREE Trial $12M x 1.3x
SPCB Unlock Forecast - 30 Days FREE Trial $24M -0.9x 1.8x
SPI Unlock Forecast - 30 Days FREE Trial $10M -1.3x 0.8x
STM Unlock Forecast - 30 Days FREE Trial $24545M x 1.4x
STMEF Unlock Forecast - 30 Days FREE Trial $24964M x 1.4x
SWKS Unlock Forecast - 30 Days FREE Trial $11177M 20.5x 1.9x
SYNA Unlock Forecast - 30 Days FREE Trial $2794M 15.9x 2.0x
TE Unlock Forecast - 30 Days FREE Trial $238M x 1.1x
TSEM Unlock Forecast - 30 Days FREE Trial $7562M x 2.9x
TXN Unlock Forecast - 30 Days FREE Trial $168185M 33.4x 10.3x
TYGO Unlock Forecast - 30 Days FREE Trial $94M -0.9x 55.5x
UCTT Unlock Forecast - 30 Days FREE Trial $1270M -331.9x 1.8x
VIAV Unlock Forecast - 30 Days FREE Trial $2734M 78.6x 3.5x
VLN Unlock Forecast - 30 Days FREE Trial $208M x 1.8x
WISA Unlock Forecast - 30 Days FREE Trial $9M -0.1x 2.0x
WOLF Unlock Forecast - 30 Days FREE Trial $195M -1.3x 1.0x

Frequently Asked Questions - SYNAPTICS Inc Stock Forecast

How accurate are SYNAPTICS Inc stock predictions?

Our AI model demonstrates 58% historical accuracy for SYNA predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence SYNAPTICS Inc stock price forecasts?

Our analysis considers SYNAPTICS Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is SYNAPTICS Inc a good investment in 2025?

Based on our AI analysis, SYNAPTICS Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are SYNAPTICS Inc forecasts updated?

SYNAPTICS Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced SYNAPTICS Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for SYNAPTICS Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...